Search clinical trials for: Bevacizumab Nab paclitaxel (intense dose-dense)
Total 83 results
-
Tongji HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Qilu... and other collaboratorsNot yet recruiting
-
Shantou Central HospitalRecruiting
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
Chang Gung Memorial HospitalRecruitingMetastatic Pancreatic AdenocarcinomaTaiwan
-
Chap, Linnea I., M.D.Genentech, Inc.UnknownBreast CancerUnited States
-
Pancreatic Cancer Action NetworkActive, not recruitingMetastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
M.D. Anderson Cancer CenterLyvgen Biopharma Holdings LimitedRecruitingGastric Cancer | Metastatic Uveal Melanoma | Metastatic Head and Neck Carcinoma | Metastatic Hepatocellular Carcinoma | Metastatic Ovarian Carcinoma | Metastatic Soft Tissue Sarcoma | Metastatic Esophageal | Metastatic HPV Related Solid TumorsUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Ovarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Malignant Peritoneal Neoplasm | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell... and other conditionsUnited States
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Peking UniversityQilu Pharmaceutical Co., Ltd.RecruitingNeuroendocrine CarcinomaChina
-
Famewave Ltd.Bristol-Myers SquibbActive, not recruitingMelanoma | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Non Small Cell Lung Cancer | Colorectal Adenocarcinoma | Papillary Thyroid CancerSpain, United States, Israel
-
Erasme University HospitalJules Bordet Institute; University Hospital St Luc, Brussels; Belgian Group of...RecruitingPancreatic Adenocarcinoma | Borderline Resectable Pancreatic Adenocarcinoma | Pancreatic NeoplasmBelgium
-
Fudan UniversityNot yet recruitingNon-small Cell Lung Cancer Metastatic
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Georgetown UniversityWithdrawnMetastatic Pancreatic CancerUnited States
-
CelgeneCompletedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.; Celgene CorporationCompleted
-
ProDa BioTech, LLCUniversity of Alabama at Birmingham; Georgia State UniversityRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPoorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVA Thyroid Gland...United States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Gastrointestinal Stromal Tumor (GIST)United States
-
Sichuan Cancer Hospital and Research InstituteRecruitingLung Diseases | Thoracic Neoplasms | Non-small Cell Lung Cancer | Pulmonary Sarcomatoid CarcinomaChina
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma AJCC v7United States
-
Institut fuer FrauengesundheitMerck Sharp & Dohme LLC; Celgene CorporationCompletedMalignant Neoplasm of BreastGermany
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Lu Wang, MD, PhDRecruitingGallbladder Cancer | Initially Unresectable | the First Line TreatmentChina
-
Fudan UniversityNot yet recruitingPancreatic Cancer
-
University of ArizonaWithdrawnMetastatic Melanoma | Brain MetastasesUnited States
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedBreast CancerUnited States
-
Infinity Pharmaceuticals, Inc.Roche Pharma AGActive, not recruitingRenal Cell Carcinoma | Breast CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Hartford Hospital; Maastricht University and other collaboratorsCompleted
-
Shanghai Chest HospitalRecruitingNon Small Cell Lung CancerChina
-
M.D. Anderson Cancer CenterCompleted
-
ImmunityBio, Inc.Unknown
-
University of Tennessee Cancer InstituteGenentech, Inc.; Celgene Corporation; National Comprehensive Cancer NetworkUnknownBreast CancerUnited States
-
Tesaro, Inc.Active, not recruitingNeoplasms | Solid Tumor | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited States
-
Genentech, Inc.Completed
-
ImmunityBio, Inc.Withdrawn
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
CelgeneCompletedMetastatic Pancreas AdenocarcinomaUnited States
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions